Pharmafile Logo

Peter Impey

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

Inizio

Novartis Gehry Building

Novartis ‘reviewing options’ for Alcon division

Possible sale or spin-off in store for eyecare unit as firm reports Q4 operating loss of $132m

- PMLiVE

Fishawack undergoes management buyout

Oliver Dennis and Dominic Miller will continue to lead the communications firm

- PMLiVE

Former Novartis exec Richard Smith joins EMD Serono

He becomes senior vice president and head of US fertility and endocrinology

- PMLiVE

David Epstein joins Flagship Pioneering as executive partner

He most recently served as CEO of Novartis Pharmaceuticals

- PMLiVE

Managed Access Programmes: a powerful source of real-world insight

MAPs represent a unique opportunity to gather evidence from a cohort of patients receiving the same treatment, across multiple countries prospectively before launch

Microsoft India launches AI eyecare research network

Will harness machine learning predictive models to tackle vision problems

- PMLiVE

Two new hepatitis C therapies fast-tracked in Europe

EMA speeds review process for Gilead and AbbVie treatments

Actelion HQ Switzerland

Actelion reports late-stage trial failure as J&J talks continue

MAESTRO trial results disappointing but unlikely to lead to a breakdown in talks

- PMLiVE

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

- PMLiVE

AZ drug discovery robot programed for cancer research

Firm says NiCoLA-B is world's most advanced drug discovery robot

UK flag

Life sciences to play key role in UK’s post-Brexit strategy

Prime minister unveils plans to boost jobs, growth and commercialise country’s science base

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links